Brian Lortie, president and CEO at Uniquity Bio, offered up key insights on building teams, securing capital, and operating with efficiency during a recent Business of Biotech podcast recording.

A benevolent, but shortsighted biotechnology CEO may be willing to sustain an ill-conceived operating model rather than seek a business relationship that might result in job losses for key ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

today announced the planned departures of two members of its executive leadership team as the company continues to align its structure with its evolving business model and modernization strategy.

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

The nonprofit incubator said it will take over the 33,000-square-foot building in Richmond, which also possesses manufacturing capability. © 2025 American City ...

After disappointing trial results for its melanoma and ovarian cancer treatments, Mural Oncology announced Wednesday it will cut about 104 positions, or about 90% of its workforce. The company ...

“It’s a business model to suppress wages,” said Doug Parton of Ironworkers Local 97. The union represents about 2,400 ironworkers across B.C. and the Yukon. While the federal government says ...

As organizations reinvent for the AI era, business leaders say they’re moving toward a new enterprise technology operating model. Here’s how to get started. You don’t need an LLM to tell you ...

UNITY Biotechnology (UBX) announced that the peer-reviewed journal NEJM Evidence published results from the Phase 2 BEHOLD study of UBX1325 in patients with diabetic macular edema. As reported in ...

Showcase your company news with guaranteed exposure both in print and online The Future of Bay Area Biotech: Searching For Answers The Small Business Leaders awards program honors the dedicated ...